Quantinno Capital Management LPQuantinno Capital Management LP

Institutional investor · Portfolio as of Q3 2019

SEC EDGAR SourceSEC Filings

Top Holdings370 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
HFCHFCDelisted

HOLLYFRONTIER CORP

15,541$834,0000.6%
2 qtrssince 2019-Q2
Unchanged
0

GENTEX CORP

29,759$819,0000.6%$18.35+35.15%
3 qtrssince 2019-Q1
Decreased
0

ORION S.A.

48,743$814,0000.5%$15.970.00%
1 qtr
New
48

HERSHEY CO/THE

5,175$802,0000.5%$90.34+47.14%
4 qtrssince 2018-Q4
Unchanged
0

PEDIATRIX MEDICAL GROUP INC

35,364$800,0000.5%$22.350.00%
1 qtr
New
48

LULULEMON ATHLETICA INC

4,041$778,0000.5%$163.87+15.77%
3 qtrssince 2019-Q1
Decreased
0

KIMBERLY-CLARK CORP

5,457$775,0000.5%$91.13+25.11%
4 qtrssince 2018-Q4
Unchanged
0

MARATHON PETROLEUM CORP

12,504$760,0000.5%$51.350.00%
1 qtr
New
48

SALLY BEAUTY HLDGS INC

51,004$759,0000.5%$15.160.00%
1 qtr
New
48

SCHWAB (CHARLES) CORP

18,131$758,0000.5%$37.950.00%
1 qtr
New
48

LOGMEIN INC

10,652$756,0000.5%
1 qtr
New
48

COMMVAULT SYS INC

16,892$755,0000.5%$43.740.00%
1 qtr
New
48

STRATEGY INC

5,067$752,0000.5%$13.55+8.47%
4 qtrssince 2018-Q4
Increased
47
ETFCETFCDelisted

E TRADE FINANCIAL CORP

17,180$751,0000.5%
1 qtr
New
48
CMACMADelisted

COMERICA INC

11,314$747,0000.5%$49.72-2.57%
3 qtrssince 2019-Q1
Increased
56

CDK GLOBAL INC

15,364$739,0000.5%
1 qtr
New
41

QUEST DIAGNOSTICS INC

6,736$721,0000.5%$92.620.00%
1 qtr
New
41
TATARODelisted

TARO PHARMACEUTICAL INDS LTD

9,351$706,0000.5%
2 qtrssince 2019-Q2
Increased
33

AMERICAN EQUITY INVT LIFE

29,024$702,0000.5%
2 qtrssince 2019-Q2
Increased
46

SYNAPTICS INC

17,466$698,0000.5%$39.620.00%
1 qtr
New
41
$148.5M
AUM
370
Positions
Q3 2019
Filing
Rating · 2.0
Quarterly Portfolio Change
+27%Q1'19$156.1M+9%Q2'19$170.4M-13%Q3'19$148.5M
Activity profile
$ moved · Q3'19
New38%Increased5%Decreased9%Exited48%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 quarters
<1Q30%1-4Q70%1-2Y0%2Y+1%

Quantinno Capital Management LP manages $148.5M across 370 positions as of Q3 2019. Top holdings: HFC (0.6%), GNTX (0.6%), OEC (0.5%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2/5.0.

Q3 2019 Summary

Active quarter - 153 new positions, 202 exits, 51 increased. Top move: CMA (INCREASED, conviction 56). Portfolio: $148M across 370 positions.

Top holdings by portfolio weight

Total AUM$148M
HFC0.56%
GNTX0.55%
OEC0.55%
HSY0.54%
MD0.54%
LULU0.52%
KMB0.52%
MPC0.51%
SBH0.51%
SCHW0.51%
Other0.51%

Portfolio allocation by GICS sector

Sectors11
Technology17.91%
Unknown16.13%
Industrials14.92%
Consumer Cyclical14.89%
Financial Services9.83%
Healthcare7.14%
Consumer Defensive7.12%
Energy3.74%
Basic Materials3.53%
Communication Services2.57%
Other2.23%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Unknown, Industrials
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record57
Conviction46
Concentration34
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AFLAFLAFLAC INC
Q3 2024 Q2 2026+455,207 shares+$57.5M
8Q
AGNCAGNCAGNC INVESTMENT CORP
Q3 2024 Q2 2026+438,342 shares+$4.8M
8Q
TTAT&T INC
Q3 2024 Q2 2026+3.3M shares+$68M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used